Transcriptional regulation of lipopolysaccharide (LPS)-induced Toll-like receptor (TLR) expression in murine macrophages: Role of interferon regulatory factors 1 (IRF-1) and 2 (IRF-2)

Journal of Endotoxin Research

Volumn 12, Issue 5, 2006, Pages 285-295

  Nhu, M Quan ^a   Cuesta, Natalia ^a   Vogel, Stefanie N ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Gene expression; Interferon regulatory factors; Macrophage; Toll like receptor; Transcriptional regulation

Indexed keywords

INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 2; LIPOPOLYSACCHARIDE; MESSENGER RNA; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 9;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE MUTATION; GENE TARGETING; GENETIC ANALYSIS; IMMUNE RESPONSE; INNATE IMMUNITY; KINETICS; MACROPHAGE; MALE; MOUSE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; UPREGULATION; ANIMAL; C57BL MOUSE; CELL CULTURE; DRUG EFFECT; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PERITONEUM MACROPHAGE;

MURINAE;

ANIMALS; CELLS, CULTURED; GENE EXPRESSION REGULATION; INTERFERON REGULATORY FACTOR-1; INTERFERON REGULATORY FACTOR-2; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; RNA, MESSENGER; TOLL-LIKE RECEPTORS; TRANSCRIPTION, GENETIC;

EID: 34249004485     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1177/09680519060120050401     Document Type: Article

References (58)

1. Akira S., Takeda K. Toll-like receptor signaling. Nat Rev Immunol 2004; 4: 499-511.
2. Dunne A., O'Neill LA Adaptor usage and Toll-like receptor signaling specificity. FEBS Lett 2005; 579: 3330-3335.
3. Ozinsky A., Underhill DM, Fontenot JD et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc Natl Acad Sci USA 2000; 97: 13766-13771.
4. Zhang H., Tay PN, Cao W., Li W., Lu J. Integrin-nucleated Toll-like receptor (TLR) dimerization reveals subcellular targeting of TLRs and distinct mechanisms of TLR4 activation and signaling. FEBS Lett 2002; 532: 171-176.
5. Lee HK, Dunzendorfer S., Tobias PS Cytoplasmic domain-mediated dimerizations of Toll-like receptor 4 observed by beta-lactamase enzyme fragment complementation. J Biol Chem 2004; 279: 10564-10574.
6. Toshchakov V., Jones BW, Perera PY et al. TLR4, but not TLR2, mediates IFN-β-induced STAT1α/β-dependent gene expression in macrophages. Nat Immunol 2002; 3: 392-398.
7. Vogel SN, Fitzgerald KA, Fenton MJ TLRs: Differential adapter utilization by Toll-like receptors mediates TLR-specific patterns of gene expression. Mol Intervent 2003; 3: 466-477.
8. Moynagh PN TLR signaling and activation of IRFs: Revisiting old friends from the NF-kB pathway. Trends Immunol 2005; 26: 469-476.
9. Taniguchi T., Ogasawara K., Takaoka A., Tanaka N. IRF family of transcription factors as regulators of host defense. Annu Rev Immunol 2001; 19: 623-655.
10. Miyamoto M., Fujita T., Kimura Y. et al. Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements. Cell 1988; 54: 903-913.
11. Harada H., Fujita T., Miyamoto M. et al. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 1989; 58: 729-739.
12. Sato M., Tanaka N., Hata N., Oda E., Taniguchi T. Involvement of the IRF family transcription factor IRF-3 in virus-induced activation of the IFN-beta gene. FEBS Lett 1998; 425: 112-116.
13. Sato M., Suemori H., Hata N. et al. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 2000; 13: 539-548.
14. Navarro L., David M. p38-dependent activation of interferon regulatory factor 3 by lipopolysaccharide. J Biol Chem 1999; 274: 35535-35538.
15. Fitzgerald KA, Rowe DC, Barnes BJ et al. LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the Toll adapters TRAM and TRIF. J Exp Med 2003; 198: 1043-1055.
16. Honda K., Yanai H., Mizutani T. et al. Role of a transductionaltranscriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proc Natl Acad Sci USA 2004; 101: 15416-15421.
17. Tsujimura H., Tamura T., Kong HJ et al. Toll-like receptor 9 signaling activates NF-kappaB through IFN regulatory factor-8/IFN consensus sequence binding protein in dendritic cells. J Immunol 2004; 172: 6820-6827.
18. Takaoka A., Yanai H., Kondo S. et al. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 2005; 434: 243-249.
19. Negishi H., Ohba Y., Yanai H. et al. Negative regulation of Toll-like receptor signaling by IRF-4. Proc Natl Acad Sci USA 2005; 102: 15989-15994.
20. Senaldi G., Shaklee CL, Guo J. et al. Protection against the mortality associated with disease models mediated by TNF and IFN-gamma in mice lacking IFN regulatory factor-1. J Immunol 1999; 163: 6820-6826.
21. Salkowski CA, Thomas KE, Cody MJ, Vogel SN Impaired IFN-gamma production in IFN regulatory factor-1 knockout mice during endotoxemia is secondary to a loss of both IL-12 and IL-12 receptor expression. J Immunol 2000; 165: 3970-3977.
22. Cuesta N., Salkowski CA, Thomas KE, Vogel SN Regulation of lipopolysaccharide sensitivity by IFN regulatory factor-2. J Immunol 2003; 170: 5739-5747.
23. Poltorak A., He X., Smirnova I. et al. Defective LPS signaling in C3H/ HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 1998; 282: 2085-2088.
24. Matsuguchi T., Musikacharoen T., Ogawa T., Yoshikai Y. Gene expressions of Toll-like receptor 2, but not Toll-like receptor 4, is induced by LPS and inflammatory cytokines in mouse macrophages. J Immunol 2000; 165: 5767-5772.
25. Medvedev AE, Kopydlowski KM, Vogel SN Inhibition of lipopolysaccharide-induced signal transduction in endotoxintolerized mouse macrophages: Dysregulation of cytokine, chemokine, and toll-like receptor 2 and 4 gene expression. J Immunol 2000; 164: 5564- 5574.
26. Zarember KA, Godowski PJ Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 2002; 168: 554-561.
27. Oshikawa K., Sugiyama Y. Gene expression of Toll-like receptors and associated molecules induced by inflammatory stimuli in the primary alveolar macrophage. Biochem Biophys Res Commun 2003; 305: 649-655.
28. Weiss DS, Raupach B., Takeda K., Akira S., Zychlinsky A. Toll-like receptors are temporally involved in host defense. J Immunol 2004; 172: 4463-4469.
29. Roger T., Miconnet I., Schiesser AL, Kai H., Miyake K., Calandra T. Critical role for Ets, AP-1 and GATA-like transcription factors in regulating mouse Toll-like receptor 4 (Tlr4) gene expression. Biochem J 2005; 387: 355-365.
30. Rehli M. Of mice and men: Species variations of Toll-like receptor expression. Trends Immunol 2002; 23: 375- 378.
31. Rehli M., Poltorak A., Schwarzfischer L., Krause SW, Andreesen R., Beutler B. PU.1 and interferon consensus sequence-binding protein regulate the myeloid expression of the human Toll-like receptor 4 gene. J Biol Chem 2000; 275: 9773-9781.
32. Musikacharoen T., Matsuguchi T., Kikuchi T., Yoshikai Y. NFkappa B and STAT5 play important roles in the regulation of mouse Toll-like receptor 2 gene expression. J Immunol 2001; 166: 4516-4524.
33. Wang T., Lafuse WP, Zwilling BS NF-kappaB and Sp1 elements are necessary for maximal transcription of Toll-like receptor 2 induced by Mycobacterium avium. J Immunol 2001; 167: 6924-6932.
34. Haehnel V., Schwarzfischer L., Fenton MJ, Rehli M. Transcriptional regulation of the human Toll-like receptor 2 gene in monocytes and macrophages. J Immunol 2002; 168: 5629-5637.
35. Heinz S., Haehnel V., Karaghiosoff M. et al. Species-specific regulation of Toll-like receptor 3 genes in men and mice. J Biol Chem 2003; 278: 21502-21509.
36. Takeshita F., Suzuki K., Sasaki S., Ishii N., Klinman DM, Ishii KJ Transcriptional regulation of the human TLR9 gene. J Immunol 2004; 173: 2552-2561.
37. McIntire FC, Sievert HW, Barlow GH, Finley RA, Lee AY Chemical, physical, and biological properties of a lipopolysaccharide from Escherichia coli K235. Biochemistry 1967; 6: 2363-2372.
38. Matsuyama T., Kimura T., Kitagawa M. et al. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell 1993; 75: 83-97.
39. Livak KJ, Schmittgen TD Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCt method Methods 2001; 25: 402-408.
40. Doyle SE, O'Connell R., Vaidya SA, Chow EK, Yee K., Cheng G. Toll-like receptor 3 mediates a more potent antiviral response than Toll-like receptor 4. J Immunol 2003; 170: 3565-3571.
41. Hida S., Ogasawara K., Sato K. et al. CD8+ T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-alpha/beta signaling. Immunity 2000; 13: 643-655.
42. Honda K., Mizutani T., Taniguchi T. Negative regulation of IFN-alpha/ beta signaling by IFN regulatory factor 2 for homeostatic development of dendritic cells. Proc Natl Acad Sci USA 2004; 101: 2416-2421.
43. Bakaletz LO Viral potentiation of bacterial superinfection of the respiratory tract. Trends Microbiol 1995; 3: 110-114.
44. Hament JM, Kimpen JL, Fleer A., Wolfs TF Respiratory viral infection predisposing for bacterial disease: A concise review. FEMS Immunol Med Microbiol 1999; 26: 189-195.
45. Hussell T., Williams A. Menage a trois of bacterial and viral pulmonary pathogens delivers coup de grace to the lung. Clin Exp Immunol 2004; 137: 8-11.
46. Doughty L., Nguyen K., Durbin J., Biron C. A role for IFN-alpha beta in virus infection-induced sensitization to endotoxin. J Immunol 2001; 166: 2658-2664.
47. Nansen A., Randrup Thomsen A. Viral infection causes rapid sensitization to lipopolysaccharide: Central role of IFN-alpha beta. J Immunol 2001; 166: 982-988.
48. Freudenberg MA, Kalis C., Chvatchko Y., Merlin T., Gumenscheimer M., Galanos C. Role of interferons in LPS hypersensitivity. J Endotoxin Res 2003; 9: 308-312.
49. Miettinen M., Sareneva T., Julkunen I., Matikainen S. IFNs activate Toll-like receptor gene expression in viral infections. Genes Immun 2001; 2: 349-355.
50. Bättcher T., von Mering M., Ebert S. et al. Differential regulation of Toll-like receptor mRNAs in experimental murine central nervous system infections. Neurosci Lett 2003; 344: 17-20.
51. Guo Z., Garg S., Hill KM et al. A distal regulatory region is required for constitutive and IFN-β-induced expression of murine TLR9 gene. J Immunol 2005; 175: 7407-7418.
52. Bovolenta C., Driggers PH, Marks MS et al. Molecular interactions between interferon consensus sequence binding protein and members of the interferon regulatory factor family. Proc Natl Acad Sci USA 1994; 91: 5046-5050.
53. Levi BZ, Hashmueli S., Gleit-Kielmanowicz M., Azriel A., Meraro D. ICSBP/ IRF-8 transactivation: A tale of protein-protein interaction. J Interferon Cytokine Res 2002; 22: 153-160.
54. Jesse TL, LaChance R., Iademarco MF, Dean DC Interferon regulatory factor-2 is a transcriptional activator in muscle where it regulates expression of vascular cell adhesion molecule-1. J Cell Biol 1998; 140: 1265-1276.
55. Vaughan PS, van der Meijden CM, Aziz F. et al. Cell cycle regulation of histone H4 gene transcription requires the oncogenic factor IRF-2. J Biol Chem 1998; 273: 194-199.
56. Luo W., Skalnik DG Interferon regulatory factor-2 directs transcription from the gp91phox promoter. J Biol Chem 1996; 271: 23445-23451
57. Chung MC, Kawamoto S. IRF-2 is involved in up-regulation of nonmuscle myosin heavy chain II-A gene expression during phorbol ester-induced promyelocytic HL-60 differentiation. J Biol Chem 2004; 279: 56042-56052.
58. Brooks AR, Nagy BP, Taylor S., Simonet WS, Taylor JM, Levy-Wilson B. Sequences containing the second-intron enhancer are essential for transcription of the human apolipoprotein B gene in the livers of transgenic mice. Mol Cell Biol 1994; 14: 2243-2256.